How has Arvinas's lessee operating lease liability payments due changed year-over-year?

Arvinas's lessee operating lease liability payments due decreased by 22.0% year-over-year, from $11.8M to $9.2M.

Arvinas ARVN Lessee Operating Lease Liability Payments Due

Lessee Operating Lease Liability Payments Due at other companies

Nurix Therapeutics, Inc.NRIX

——

Inhibrx Biosciences, Inc.INBX

——

Nuvation BioNUVB

——

Other financials

Income statement

See full

Revenue$15.6M-91.7%

Operating income-$63.8M-189%

Net income-$57.6M-169%

EPS (diluted)-$0.90-179%

Balance sheet

See full

Cash & equivalents$87.3M+7.8%

Total debt$8.6M-19.6%

Total equity$386.8M-41.4%

Total assets$647.5M-35.3%

Cash flow

See full

Operating cash flow-$69.2M+22.2%

CapEx$1.3M+225%

Free cash flow-$70.5M+21.1%

Valuation

See full

Market cap$518.11M-4.6%

Enterprise value$439.41M-7.1%

P/S5.8×+4.5×

Profitability

See full

Operating margin-283.8%-310pp

Net margin-247.5%-260pp

FCF margin-287.4%—

Returns & leverage

See full

Return on equity-42.3%-53.5pp

Debt / equity0×0.0×

Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's lessee operating lease liability payments due.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arvinas's lessee operating lease liability payments due?: Arvinas (ARVN) reported lessee operating lease liability payments due of $9.2M in Q1 2026.
How has Arvinas's lessee operating lease liability payments due changed year-over-year?: Arvinas's lessee operating lease liability payments due decreased by 22.0% year-over-year, from $11.8M to $9.2M.